Latest News and Press Releases
Want to stay updated on the latest news?
-
October 05, 2020, 17h45 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated...
-
Premier paiement d’EUR 20 millions pour l’accord de licence stratégique en Chine Collaboration avec CGN Nuclear Technology Development Co., Ltd d'une valeur minimale d’EUR 100 millions ...
-
Collaboration with CGN Nuclear Technology Development Co., Ltd worth a minimum of EUR 100 million Louvain-La-Neuve, Belgium, 24 September 2020 - IBA (Ion Beam Applications S.A., EURONEXT), the...
-
Louvain-la-Neuve, Belgique, 2 septembre 2020, 17.40 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement...
-
Louvain-la-Neuve, Belgique, 2 septembre 2020, 17.40 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du...
-
Louvain-la-Neuve, Belgium, September 2, 2020, 17.40 Summary of the notification IBA (Ion Beam Application), the world’s leading provider of proton therapy solutions for the treatment of cancer,...
-
Louvain-la-Neuve, Belgium, September 2, 2020, 17.40 Summary of the notification IBA (Ion Beam Application), the world’s leading provider of proton therapy solutions for the treatment of...
-
IBA signe un contrat pour une solution Proteus®PLUS à Chengdu, Province du Sichuan, en Chine Contrat pour 4 salles de traitement d’une valeur supérieure à EUR 50 millions Louvain-La-Neuve,...
-
IBA signs contract for Proteus®PLUS Proton Therapy Solution in Chengdu, Sichuan Province, China Four room contract worth over EUR 50 million Louvain-la-Neuve, Belgium, 1st September, 2020 - IBA (Ion...
-
IBA announces strategic licensing deal for Proteus®PLUS in China worth a minimum of EUR 100 million Collaboration with CGNNT to further strengthen access to the growing Chinese proton therapy...